• Profile
Close

Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: A prospective cohort study

PLoS Medicine Sep 04, 2021

Wang Y, Yang L, Bao H, et al. - Improved prediction of pathological complete response (pCR)/non-pCR after neoadjuvant chemoradiotherapy (nCRT) is afforded by the model combining circulating tumor DNA (ctDNA) and magnetic resonance imaging (MRI) for locally advanced rectal cancer (LARC) patients receiving nCRT followed by total mesorectal excision (TME). ctDNA affords a tool that can supplement MRI to better predict nCRT response, as well as can potentially aid selection of candidates for nonoperative treatment and guide the management approach for those with different recurrence risks.

  • A prospective cohort study of 119 LARC patients receiving nCRT followed by TME.

  • At baseline, during nCRT, and post-surgery, a total of 531 serial plasma samples were obtained.

  • Next-generation sequencing was conducted using a panel comprising 422 cancer-related genes.

  • A significant correlation of baseline ctDNA features, as well as of the clearance of ctDNA during nCRT, with pCR status was evident.

  • Predictive models based on ctDNA alone, MRI alone, and combination of ctDNA and MRI were developed, and it was revealed that the combining model showed significantly better performance in predicting pCR/non-pCR vs ctDNA alone or MRI alone.

  • Identification of potential colorectal cancer driver genes in ctDNA post-nCRT suggested a significantly worse recurrence-free survival (hazard ratio = 9.29).

  • Cases with a high risk of recurrence can be stratified by combining ctDNA with HR_feature (high-risk feature).

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay